Adempas — Medical Mutual
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) [WHO Group 4]
Initial criteria
- Persistent/recurrent CTEPH (WHO Group 4); AND
- The patient has been treated surgically, or CTEPH is inoperable; AND
- Adempas is prescribed by or in consultation with a cardiologist or pulmonologist
Reauthorization criteria
- Persistent/recurrent CTEPH (WHO Group 4); AND
- The patient has been treated surgically, or CTEPH is inoperable; AND
- Adempas is prescribed by or in consultation with a cardiologist or pulmonologist
Approval duration
1 year